Loading...
Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
BACKGROUND: Three checkpoint inhibitor drugs have been approved by the US Food and Drug Administration for use in specific types of cancers. While the results are promising, severe immunotherapy-related adverse events (irAEs) have been reported. OBJECTIVES: To conduct a systematic review of case rep...
Saved in:
| Published in: | PLoS One |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Public Library of Science
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966895/ https://ncbi.nlm.nih.gov/pubmed/27472273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0160221 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|